Texas Capital Bancshares Inc Novo Nordisk A S Transaction History

Texas Capital Bancshares Inc

$245 Million
Q4 2024

A detailed history of Texas Capital Bancshares Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Texas Capital Bancshares Inc holds 3,210 shares of NVO stock, worth $222,902. This represents 0.11% of its overall portfolio holdings.

Number of Shares

3,210

Previous 2,844 12.87%

Holding current value

$222,902

Previous $338,000 18.34%

% of portfolio

0.11%

Previous 0.18%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$85.0 - $120.04 $31,110 - $43,934	366 Added 12.87%	3,210 $276,000
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $10,240 - $12,506	86 Added 3.12%	2,844 $338,000
Q2 2024 Aug 15, 2024	SELL	$122.71 - $146.91 $1,595 - $1,909	-13 Reduced 0.47%	2,758 $393,000
Q1 2024 May 13, 2024	SELL	$102.11 - $135.92 $111,912 - $148,968	-1,096 Reduced 28.34%	2,771 $355,000
Q4 2023 Feb 08, 2024	SELL	$87.78 - $105.45 $18,082 - $21,722	-206 Reduced 5.06%	3,867 $400,000
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $183,153 - $401,873	2,014 Added 97.81%	4,073 $370,000
Q2 2023 Aug 09, 2023	SELL	$155.98 - $172.65 $4,523 - $5,006	-29 Reduced 1.39%	2,059 $333,000
Q1 2023 May 11, 2023	SELL	$132.34 - $159.14 $78,345 - $94,210	-592 Reduced 22.09%	2,088 $332,000
Q4 2022 Feb 09, 2023	SELL	$102.55 - $135.33 $717 - $947	-7 Reduced 0.26%	2,680 $362,000
Q2 2022 Aug 04, 2022	SELL	$103.24 - $121.81 $27,771 - $32,766	-269 Reduced 9.1%	2,687 $299,000
Q1 2022 May 02, 2022	SELL	$93.1 - $112.54 $1,117 - $1,350	-12 Reduced 0.4%	2,956 $328,000
Q4 2021 Feb 07, 2022	BUY	$95.88 - $117.08 $10,450 - $12,761	109 Added 3.81%	2,968 $332,000
Q3 2021 Nov 05, 2021	SELL	$84.42 - $106.62 $2,617 - $3,305	-31 Reduced 1.07%	2,859 $274,000
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $195,537 - $244,956	2,890 New	2,890 $242,000
Q1 2021 May 06, 2021	SELL	$67.06 - $75.82 $194,876 - $220,332	-2,906 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $117,685 - $135,939	-1,842 Reduced 38.8%	2,906 $203,000
Q3 2020 Nov 06, 2020	SELL	$63.69 - $70.22 $4,076 - $4,494	-64 Reduced 1.33%	4,748 $330,000
Q4 2019 Jan 30, 2020	SELL	$49.86 - $58.26 $5,235 - $6,117	-105 Reduced 2.14%	4,812 $279,000
Q3 2019 Oct 28, 2019	SELL	$47.54 - $53.43 $166,390 - $187,005	-3,500 Reduced 41.58%	4,917 $254,000
Q2 2019 Jul 19, 2019	BUY	$46.79 - $52.47 $81,040 - $90,878	1,732 Added 25.91%	8,417 $430,000
Q1 2019 Apr 23, 2019	SELL	$46.36 - $52.63 $3,106 - $3,526	-67 Reduced 0.99%	6,685 $350,000
Q4 2018 Jan 29, 2019	BUY	$41.54 - $47.25 $30,324 - $34,492	730 Added 12.12%	6,752 $311,000
Q2 2018 Jul 19, 2018	SELL	$44.29 - $50.42 $1,948 - $2,218	-44 Reduced 0.73%	6,022 $278,000
Q1 2018 Apr 25, 2018	SELL	$48.49 - $58.14 $17,650 - $21,162	-364 Reduced 5.66%	6,066 $299,000
Q4 2017 Jan 26, 2018	SELL	$47.53 - $53.73 $2,138 - $2,417	-45 Reduced 0.69%	6,430 $345,000
Q3 2017 Oct 19, 2017	BUY	$41.15 - $49.22 $266,446 - $318,699	6,475	6,475 $312,000

Others Institutions Holding NVO

# of Institutions

1,887

Shares Held

335M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $157B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bancshares Inc with notifications on news.

Account

Texas Capital Bancshares Inc Novo Nordisk A S Transaction History